|
06-15-2010, 08:06 PM
|
|||
|
|||
Micromets Cancer Missiles Lure Boehringer, Sanofi (Update1)
June 14 (Bloomberg) -- Micromet Inc. , a 17-year-old biotechnology company with no medicines on the market, is attracting attention from product-hungry drugmakers. The lure: a technology for fighting cancer without using toxic chemicals.
    
|
 |
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile | cancerfr | Head and Neck Cancer | 0 | 09-23-2010 10:49 PM |
| Sanofi-Aventis Q2 Profit Climbs - Update | cancerfr | Colon and Rectal Cancer | 0 | 07-31-2010 04:35 PM |
| Sanofi-aventis to acquire US biopharma firm TargeGen for US$ 560 mn | cancerfr | Multiple Myeloma/Other Plasma Cell Neoplasms | 0 | 07-01-2010 07:45 PM |
| Micromets Cancer Missiles Lure Boehringer, Sanofi (Update1) | cancerfr | Bone Cancer | 0 | 06-14-2010 03:56 PM |
| Sanofi CEO Sees Stunning Results for Cancer Drug (Update2) | cancerfr | Extracranial Germ Cell Tumor | 0 | 06-07-2010 07:43 PM |
Linear Mode
